Insider filing · PTCT
Mary L. Smith
Director
profile →
PTC Therapeutics, Inc.
PTCT · Healthcare · 80 filings in 24 months
ticker →
Mary L. Smith sold $1.4M of PTC Therapeutics (PTCT)
Executed Jul 9, disclosed Jul 13, 4 days later.
Value, as filed
$1.4M
15,834 sh across 2 lots
Executed
Jul 9
the trade date, as filed
Disclosed
Jul 13
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMary L. Smith (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $1.4M of PTCT (15,834 sh across 2 lots, as filed), executed Jul 9.
The name
PTCTHealthcare · PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→